Orion Oyj

OTC
ORINF
Stock
Yield per half year: +111.82%
Dividend yield: 2.11%
Sector: Healthcare

Orion Oyj

90.0090.0080.0080.0070.0070.0060.0060.0050.0050.0040.0040.0030.0030.00Sep '24Sep '24Oct '24Oct '24Nov '24Nov '24Dec '24Dec '2420252025Feb '25Feb '25Mar '25Mar '25Apr '25Apr '25May '25May '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
6/10
22.57 54.97 -58.95% 25.99 -13.16%
P/S 4.11 5.01 -17.84%
P/BV 6.08 5.89 3.16%
P/FCF 2636.36 26.54 9834.04%
Ev/Ebitda 15.51 18.25 -15.02%
Ev/S 4.18 4.52 -7.48%
Ev/FCF 2527.27 34.91 7138.82%
E/P 0.0418 1.45 -97.12%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
8/10
26.96 23.67 13.88% 29.89 -9.82%
ROE 26.93 14.7 83.13%
ROA 16.66 7.42 124.58%
ROIC 0 14.2 -100%
ROS 18.23 11.13 63.73%
ROCE 33.54 12.85 160.92%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
9/10
0.5511 2.95 -81.34% 0.4981 +10.63%
Nеt Debt/Ebitda 0.2634 0.0289 810.8%
Debt/Ratio 0.1358 0.2252 -39.71%
Debt/Equity 0.6162 0.7131 -13.58%
Debt/Net Income 0.8151 10.58 -92.29%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
5.28/10
2.11 1.72 22.52% 4.11 -48.7%
Number of years of dividend growth 1 1.67 -40.16%
DSI 0.7857 0.7773 1.08%
Average dividend growth -6.47 -391.67 -98.35%
Average percentage for 5 years 4.11 3.27 25.6%
Average percentage for payments 85.55 159.36 -46.32%
Difference from average difference in sector 0.3878

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
5/10
32.69 372.15 -91.22%
Growth impulse Ebitda in 5 years 22.19 384.66 -94.23%
Growth impulse Net Income in 5 years 27.45 281.12 -90.24%
Growth impulse FCF in 5 years -99.01 261.94 -137.8%
Growth impulse EPS in 5 years 27.66 505.21 -94.53%
IP Score
5.77/10

Similar companies

Astellas Pharma Inc.

Sinopharm Group Co., Ltd.

Roche Holding

Sinopharm Group Co., Ltd.

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription